Formation of human tissue to improve drug testing and reduce animal research

[fa icon="calendar"] Jan 19, 2018 9:30:56 AM / by Simon Padbury

StefanPrzyborskiNEWSTILEIMAGE-2REPROCELL’s Alvetex, a scaffold for 3D cell culture and bioengineered tissue models, is in the Durham University (UK) News yesterday, at https://www.dur.ac.uk/news/newsitem/?itemno=33385

Developed at the university by Professor Stefan Prsyborski, Alvetex was first commercialised by the spin-out company Reinnervate – based at NETPark in County Durham, UK. Reinnervate was acquired by REPROCELL Inc. (Japan) in 2014.

Stefan Przyborski is Professor of Cell Technology at Durham University’s Department of Biosciences and Chief Scientific Officer of REPROCELL Europe Ltd.

Says Prof Przyborski in the News article,

“The ability to grow cells in three-dimensions stemmed from basic research in our research labs at Durham University.

“We have since adapted that technology to be able to grow human tissues in vitro in the lab, which has tremendous potential benefits for future research.

“By modelling the anatomy of human tissue, which can be manipulated to simulate certain disease types, we can more effectively study the effects that drugs or other chemicals might have on these tissues.

“This also has benefits for reducing the numbers of animals used in research, as scientists are able to carry out research on more realistic human tissue models.”

Read more at: https://www.dur.ac.uk/news/newsitem/?itemno=33385

Topics: Human Tissues, Bio-engineered Tissue Models, Drug Discovery, 3D Cell Culture

Simon Padbury

Written by Simon Padbury

Strategy and Marketing Planner, REPROCELL